Smislio je lijek za ove vrste koje su nam braća i sestre; posebno se nadamo da ćemo s Yaohaijem bolje brinuti o našim kućnim ljubimcima i mačkama. Drugi se zove rekombinantni mačji serum albumin ili skraćeno FSA. Antitijela specifična za mačke - Vrsta proteina koji je prisutan u krvi mačaka, stoga FSA Ali ovaj FSA nije izveden iz autentične mace, što ga čini "rekombinantnim" FSA Kako katapaktu možemo dovesti do dublje ilustracije Mačka dečki su ovisni. — Kao potpuno novi i nezamjenjivi lijek, vremenski test / izvrsni rezultati za sve ostale prehrambene proizvode od sirutke koji su trenutno dostupni.
FSA volonteri marljivo rade na brizi za bolesne mačke. 5) Zaštita proteina Kada se mačke razbole, mogu izgubiti dosta važnih proteina u tijelu. Gubitak proteina ih je također mogao učiniti slabima i umornima tako da su se njihova tijela mogla boriti protiv bolesti. Neka FSA nadomjesti ono što su izgubili u proteinima. Ali to može učiniti da druga loša situacija prođe brže i vratiti ih na teren prije nego što shvatite. I za razliku od IFAT-a, Yaohai Rekombinantni ljudski serumski albumin (HSA) može se koristiti na mačkama koje nikad nisu bile bolesne. Poboljšanjem njihovog imunološkog sustava sprječavate ih da se uopće razbole.
Izuzetno ključno jer je FSA zamjena za izgubljene proteine kod mačaka. Ovo im je potrebno za oporavak. Na primjer, upravo bi taj protein mogao učiniti da se mačka osjeća kao da je u porastu i može brže ozdraviti ako je bolesna. Ovo je također preventiva za održavanje zdravlja kao FSA. To se pretvara u injekciju koju mačke dobivaju. Yaohai Fermentacija plazmida visokog prinosa može spriječiti da se mačka uopće razboli, to je super. FSA postoji u svim mačkama što ih čini vrlo jakim i zdravim tijekom života.
Dok su ovi pisci rada na komad radili svoj posao, nekoliko je istraživača pokušalo otkriti i razumjeti prednosti koje FSA ima za mačke. “Iako prepoznaju FSA kao dobru stvar za bolesne mačke, vide to i kao nešto što će spriječiti da se zdrave mačke razbole. Stoga je FSA definitivno jedan od ključnih lijekova koje koristimo u borbi protiv očuvanja zdravlja naših mačaka. S ovim informacijama, kao pioniri nove ere u Yaohaiju Albumin vezanje proizvodnje hormona rasta, više će mačaka sada imati koristi od dragocjenog lijeka koji se može napraviti pomoću njega. Ovo je veliki korak naprijed u medicini za životinje i prilika za promjenu života bezbrojnih mačaka.
U budućnosti će FSA biti važnija za mačke. Zaključak: buduća istraživanja namijenjena raščlanjivanju FSA pružit će nove mehanizme koji okružuju korisnost FSA i na kraju će dovesti do novih mogućnosti za FSA u biomedicini. Uz dužnu zahvalnost, Yaohai ima za cilj učiniti FSA univerzalnom proizvodnjom koja će omogućiti da se njime u budućnosti pomaže više populacija mačaka. Budući da su mačke obavezan mesožder i zadovoljavaju sve zahtjeve hidrona kroz konzumaciju mesa, FSA će vjerojatno ostati tražena u veterinarskoj medicini još nekoliko godina.
Yaohai Bio-Pharma, a leader in Recombinant Feline Serum Albumin (FSA) of microbial biologics, is located in Jiangsu. We are focusing on microbially produced therapeutics and vaccines that are suited for human, veterinary, and pet health management. We have modern RD as well as manufacturing technology platforms that cover the entire process, from engineering microbial strains, cell banking, process and method development, through to commercial and clinical manufacturing, making sure that we can ensure the successful supply of the most cutting-edge solutions. We have acquired a large amount of experience in the microbial bio processing field. More than 200 projects have been completed successfully and we support our clients in overcome regulations such as those of the US FDA and EU EMA. We also aid them with Australia TGA and China NMPA. We are able to respond rapidly to market requirements and offer customized CDMO services thanks to our experience and expertise.
Yaohai Bio-Pharma, a top 10 manufacturer of biological products, specializes in microbial fermentation. We have created a Recombinant Feline Serum Albumin (FSA) manufacturing facility with robust RD capabilities and cutting-edge manufacturing facilities. Five drug substance production lines conforming to GMP standards to purify and ferment microbial cells, as well as two fill and finish lines for vials and cartridges, as well as needles that are pre-filled, are available. The available fermentation scales include 100L, 500L, 1000L and 2000L. Specifications for filling vials range from 1ml - 25ml. the pre-filled cartridge or syringe filling specifications range from between 1-3ml. The production workshop is cGMP-compliant and provides a stable supply of commercial products and clinical samples. Our facility produces large molecules that are shipped worldwide.
Yaohai BioPharma, a top 10 Microbial CDMO, integrates quality and regulatory matters. We have a quality system that is fully compliant with the current GMP standards, as well as international regulations. Our team of regulatory experts has a deep understanding of world-wide regulatory frameworks. This lets us accelerate biological launches. We are able to guarantee traceable production procedures and high-quality products that conform with regulations from the US FDA, Recombinant Feline Serum Albumin (FSA), Australia TGA, and China NMPA. Yaohai BioPharma has successfully passed an on-site audit conducted of the European Union's Qualified Person (QP) for our GMP quality system and production site. We also have been through the initial certification audits of the ISO9001 Quality Management System and ISO14001 Environmental Management System.
Yaohai Bio-Pharma is Recombinant Feline Serum Albumin (FSA) in microbial-derived biologics. We offer custom RD as well as manufacturing solutions, while minimising the risk. We've been involved in numerous modalities like recombinant subunit vaccines, peptides hormones, cytokines growth factors, single-domain antibodies, enzymes, plasmid DNA, the mRNA, and other. We are experts in several Microbial hosts, such as yeast extracellular and intracellular (yield up to 15 grams per liter) bacteria periplasmic secretion as well as soluble intracellular inclusion bodies (yield up to 10 grams/L). Additionally, we have developed the BSL-2 microbial fermentation platform for the development of bacterial vaccines. We have a track record of improving production processes, thereby increasing yields, and reducing costs. With a highly efficient technology team, we guarantee prompt and reliable project delivery and bring your products to market quicker.